1790 Targeting filarial kinases with human homologues: repurposed, orally available, approved tyrosine kinase inhibitors (TKI) act as micro- and macrofilaricidal agents at concentrations easily achievable in vivo

Podobne knjige/članki

• Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration–Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal
  od: O'Connell, Elise M., et al.
  Izdano: (2015)
• Lymphangiogenesis and Lymphatic Remodeling Induced by Filarial Parasites: Implications for Pathogenesis
  od: Bennuru, Sasisekhar, et al.
  Izdano: (2009)
• Mining filarial genomes for diagnostic and therapeutic targets
  od: Bennuru, Sasisekhar, et al.
  Izdano: (2017)
• Defining the target and the effect of imatinib on the filarial c-Abl homologue
  od: O’Connell, Elise M., et al.
  Izdano: (2017)
• Elevated Levels of Plasma Angiogenic Factors Are Associated with Human Lymphatic Filarial Infections
  od: Bennuru, Sasisekhar, et al.
  Izdano: (2010)